Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021  

作　　者：Wen-Xing Ding Hua Wang Yuxia Zhang On behalf of the Chinese American Liver Society Symposium Organizing Committee 

机构地区：[1]Department of Pharmacology,Toxicology and Therapeutics,University of Kansas Medical Center,Kansas City,KS,USA [2]Department of Oncology,The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China [3]不详

出　　处：《Liver Research》2022年第1期50-57,共8页肝脏研究（英文）

摘　　要：The 4th Chinese American Liver Society(CALS)/Society of Chinese Bioscientists in America(SCBA)Hepatology Division Annual Symposium was held virtually on October 29e30,2021.The goal of the CALS Symposium was to present and discuss the recent research data on the pathogenesis and therapeutic targets of liver diseases among the CALS members,trainees and invited speakers.Here we briefly introduce the history of the CALS/SCBA Hepatology Division and highlight the presentations that focus on the current progresses on basic and translational research in liver metabolism,bile acid biology,alcohol-related liver disease,drug-induced liver injury,cholestatic liver injury,non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and liver cancer.

关 键 词：Liver diseases Alcohol-related liver disease(ALD) CHOLESTASIS Drug-induced liver injury(DILI) Hepatocellular carcinoma(HCC) Non-alcoholic fatty liver disease(NAFLD) Non-alcoholic steatohepatitis(NASH) SYMPOSIUM 

分 类 号：R575[医药卫生—消化系统] R-2[医药卫生—内科学]